UBS Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $109M | Sell |
|
|||||
|
2025
Q1 | $181M | Buy |
|
|||||
|
2024
Q4 | $211M | Buy |
|
|||||
|
2024
Q3 | $152M | Buy |
|
|||||
|
2024
Q2 | $128M | Buy |
|
|||||
|
2024
Q1 | $108M | Buy |
|
|||||
|
2023
Q4 | $86.8M | Sell |
|
|||||
|
2023
Q3 | $103M | Buy |
|
|||||
|
2023
Q2 | $89.5M | Buy |
|
|||||
|
2023
Q1 | $85.1M | Buy |
|
|||||
|
2022
Q4 | $80.8M | Buy |
|
|||||
|
2022
Q3 | $36.9M | Sell |
|
|||||
|
2022
Q2 | $61M | Buy |
|
|||||
|
2022
Q1 | $62.9M | Sell |
|
|||||
|
2021
Q4 | $181M | Sell |
|
|||||
|
2021
Q3 | $294M | Buy |
|
|||||
|
2021
Q2 | $97.4M | Sell |
|
|||||
|
2021
Q1 | $61.1M | Buy |
|
|||||
|
2020
Q4 | $34.6M | Buy |
|
|||||
|
2020
Q3 | $20.3M | Buy |
|
|||||
|
2020
Q2 | $17.5M | Buy |
|
|||||
|
2020
Q1 | $3.15M | Buy |
|
|||||
|
2019
Q4 | $208K | Sell |
|
|||||
|
2019
Q3 | $952K | Buy |
|
|||||
|
2019
Q2 | $374K | Buy |
|
|||||
|
2019
Q1 | $191K | Buy |
|
|||||
|
2018
Q4 | $34K | Buy |
|